Your browser doesn't support javascript.
loading
Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real-World Population.
Kilpatrick, Ryan D; Chiuve, Stephanie E; Leslie, William D; Wegrzyn, Lani R; Gao, Wei; Yang, Hongbo; Soliman, Ahmed M; Snabes, Michael C; Koenigsberg, Sarah; Zhong, Jia; Xiang, Cheryl; Watts, Nelson B.
Affiliation
  • Kilpatrick RD; Global Epidemiology, Pharmacovigilance & Patient Safety, AbbVie, Inc. Chicago IL USA.
  • Chiuve SE; Global Epidemiology, Pharmacovigilance & Patient Safety, AbbVie, Inc. Chicago IL USA.
  • Leslie WD; University of Manitoba Winnipeg Manitoba Canada.
  • Wegrzyn LR; Global Epidemiology, Pharmacovigilance & Patient Safety, AbbVie, Inc. Chicago IL USA.
  • Gao W; Analysis Group, Inc. Boston MA USA.
  • Yang H; Analysis Group, Inc. Boston MA USA.
  • Soliman AM; Health Economics and Outcomes Research, AbbVie, Inc. Chicago IL USA.
  • Snabes MC; Clinical Development, Global Pharmaceutical Research and Development, AbbVie, Inc Chicago IL USA.
  • Koenigsberg S; Analysis Group, Inc. Boston MA USA.
  • Zhong J; Analysis Group, Inc. Boston MA USA.
  • Xiang C; Analysis Group, Inc. Boston MA USA.
  • Watts NB; Mercy Health Osteoporosis and Bone Health Services Cincinnati OH USA.
JBMR Plus ; 4(12): e10401, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33354641
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JBMR Plus Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: JBMR Plus Year: 2020 Document type: Article Country of publication: